Status: Not yet recruiting
Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates
Pivotal study to assess safety and performance of Neola®, a novel lung monitoring device for neonates
Participants needed: 22
Trial details
Age: 1-44Biological sex: AllType: InterventionalSponsor: Neola Medical IncUpdated: Jul 11, 2025Locations: 2
Eligibility criteria
Preterm or term born neonates with gestational age between 26 and 40 weeks [+5]
Known cardiopulmonary congenital anomalies [+4]